Literature DB >> 1471476

The coexistence of Alzheimer's disease and Creutzfeldt-Jakob disease in a patient with dementia of long duration.

T Muramoto1, T Kitamoto, H Koga, J Tateishi.   

Abstract

We report here a 75-year-old-male with a slowly progressive dementia of 5-year duration along with a rapid exacerbation of symptoms in the terminal 3 months. Neuropathological examinations revealed findings consistent with conspicuous Alzheimer's disease and mild Creutzfeldt-Jakob disease (CJD). The plaque amyloid was exclusively composed of beta-protein. The immunohistochemistry of prion protein using hydrolytic autoclaving pretreatment showed diffuse gray matter stainings in the sections of both the cerebral and cerebellar cortices. This method was thus considered useful in confirming the diagnosis of CJD for this case.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1471476     DOI: 10.1007/bf00227747

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  13 in total

1.  The primary structure of the prion protein influences the distribution of abnormal prion protein in the central nervous system.

Authors:  T Kitamoto; K Doh-ura; T Muramoto; M Miyazono; J Tateishi
Journal:  Am J Pathol       Date:  1992-08       Impact factor: 4.307

2.  N-terminal sequence of prion protein is also integrated into kuru plaques in patients with Gerstmann-Sträussler syndrome.

Authors:  T Kitamoto; T Muramoto; C Hilbich; K Beyreuther; J Tateishi
Journal:  Brain Res       Date:  1991-04-05       Impact factor: 3.252

3.  Coexistence of Creutzfeldt-Jakob disease and Alzheimer's disease in the same patient.

Authors:  P Brown; F Jannotta; C J Gibbs; H Baron; D C Guiroy; D C Gajdusek
Journal:  Neurology       Date:  1990-02       Impact factor: 9.910

4.  Organ distribution of proteinase-resistant prion protein in humans and mice with Creutzfeldt-Jakob disease.

Authors:  T Kitamoto; S Mohri; J Tateishi
Journal:  J Gen Virol       Date:  1989-12       Impact factor: 3.891

5.  Diagnosis of Creutzfeldt-Jakob disease by Western blot identification of marker protein in human brain tissue.

Authors:  P Brown; M Coker-Vann; K Pomeroy; M Franko; D M Asher; C J Gibbs; D C Gajdusek
Journal:  N Engl J Med       Date:  1986-02-27       Impact factor: 91.245

6.  Increased tau accumulation in senile plaques as a hallmark in Alzheimer's disease.

Authors:  R W Shin; K Ogomori; T Kitamoto; J Tateishi
Journal:  Am J Pathol       Date:  1989-06       Impact factor: 4.307

7.  Abnormal isoform of prion proteins accumulates in the synaptic structures of the central nervous system in patients with Creutzfeldt-Jakob disease.

Authors:  T Kitamoto; R W Shin; K Doh-ura; N Tomokane; M Miyazono; T Muramoto; J Tateishi
Journal:  Am J Pathol       Date:  1992-06       Impact factor: 4.307

8.  Hydrated autoclave pretreatment enhances tau immunoreactivity in formalin-fixed normal and Alzheimer's disease brain tissues.

Authors:  R W Shin; T Iwaki; T Kitamoto; J Tateishi
Journal:  Lab Invest       Date:  1991-05       Impact factor: 5.662

9.  The sequential development of abnormal prion protein accumulation in mice with Creutzfeldt-Jakob disease.

Authors:  T Muramoto; T Kitamoto; J Tateishi; I Goto
Journal:  Am J Pathol       Date:  1992-06       Impact factor: 4.307

10.  Creutzfeldt-Jakob disease prion proteins in human brains.

Authors:  J M Bockman; D T Kingsbury; M P McKinley; P E Bendheim; S B Prusiner
Journal:  N Engl J Med       Date:  1985-01-10       Impact factor: 91.245

View more
  8 in total

1.  Molecular cross talk between misfolded proteins in animal models of Alzheimer's and prion diseases.

Authors:  Rodrigo Morales; Lisbell D Estrada; Rodrigo Diaz-Espinoza; Diego Morales-Scheihing; Maria C Jara; Joaquin Castilla; Claudio Soto
Journal:  J Neurosci       Date:  2010-03-31       Impact factor: 6.167

2.  Prion strain interactions are highly selective.

Authors:  K Peter R Nilsson; Shivanjali Joshi-Barr; Olivia Winson; Christina J Sigurdson
Journal:  J Neurosci       Date:  2010-09-08       Impact factor: 6.167

Review 3.  Cross currents in protein misfolding disorders: interactions and therapy.

Authors:  Rodrigo Morales; Kristi M Green; Claudio Soto
Journal:  CNS Neurol Disord Drug Targets       Date:  2009-11       Impact factor: 4.388

4.  Alzheimer-type neuropathology in a 28 year old patient with iatrogenic Creutzfeldt-Jakob disease after dural grafting.

Authors:  M Preusser; T Ströbel; E Gelpi; M Eiler; G Broessner; E Schmutzhard; H Budka
Journal:  J Neurol Neurosurg Psychiatry       Date:  2006-03       Impact factor: 10.154

5.  Codistribution of amyloid beta plaques and spongiform degeneration in familial Creutzfeldt-Jakob disease with the E200K-129M haplotype.

Authors:  Nupur Ghoshal; Ignazio Cali; Richard Justin Perrin; S Andrew Josephson; Ning Sun; Pierluigi Gambetti; John Carl Morris
Journal:  Arch Neurol       Date:  2009-10

6.  Translation of the prion protein mRNA is robust in astrocytes but does not amplify during reactive astrocytosis in the mouse brain.

Authors:  Walker S Jackson; Clemens Krost; Andrew W Borkowski; Lech Kaczmarczyk
Journal:  PLoS One       Date:  2014-04-21       Impact factor: 3.240

Review 7.  Hijacking PrP(c)-dependent signal transduction: when prions impair Aβ clearance.

Authors:  Julia Hernandez-Rapp; Séverine Martin-Lannerée; Théo Z Hirsch; Jean-Marie Launay; Sophie Mouillet-Richard
Journal:  Front Aging Neurosci       Date:  2014-02-28       Impact factor: 5.750

8.  Understanding Creutzfeldt-Jackob disease from a viewpoint of amyloidogenic evolvability.

Authors:  Makoto Hashimoto; Gilbert Ho; Yoshiki Takamatsu; Ryoko Wada; Shuei Sugama; Masaaki Waragai; Eliezer Masliah; Takato Takenouchi
Journal:  Prion       Date:  2020-12       Impact factor: 3.931

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.